Catalog No. 8888160341; Umbilical Vessel Catheter 5 French single lumen Recall
Catalog No. 8888160341; Umbilical Vessel Catheter 5 French single lumen
FDA recall Class II
Ongoing
FDA lists this Class II recall for Catalog No. 8888160341; Umbilical Vessel Catheter 5 French single lumen. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-1873-2025
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- May 2, 2025
- FDA report date
- Jun 4, 2025
- Quantity in commerce
- 51378
- Distribution
- See key details
- FDA cause
- Package design/selection
What is being recalled?
Catalog No. 8888160341; Umbilical Vessel Catheter 5 French single lumen
Affected model & UDI checker
Search the exact identifiers published for Z-1873-2025.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| 8888160341 | Catalog No. 8888160341; Umbilical Vessel Catheter 5 French single lumen | Check source notice | Not specified |
FDA code information
UDI-DI (ea) 10192253040319; UDI-DI (box) 50192253040317 Lots 2427700158 2425600066 2433000005 2427700160 2425600067 2425600070 2415100113 2425600071 2427700159 2415100110 2412100093 2433000095 2425600069 2425600077 2415100116 2425600063 2425600074 2415100115 2415100114 2412100096 2425600072 2425600075 2404400061 2425600064 2415100106 2425600076 2415100107 2415100112 2425600073 2425600065 2404400062 2404400065 2415100093 2415100109 2415100111 2433000094
Why was this product recalled?
Packaging defect may compromise sterility of the product. Use of a non-sterile product on the patient could lead to infection in neonates.
What actions did Cardinal Health 200, LLC take?
The firm started notifying customers on May 2, 2025 via Urgent Medical Device Product Recall letters. Customers were instructed to remove any devices currently in use. In addition, customers should review their inventory and segregate/quarantine all affected product. If product has been further distributed, the distributor should notify all downstream customers. Customers are asked to return an acknowledgement form whether they have affected product or not. Customers should contact the firm to arrange for return and credit or questions regarding suitable alternative products. For questions related to this recall, please contact the market action team at: GMB-FieldCorrectiveAction@cardinalhealth.com or call 800-292-9332.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA notice posted
FDA classification recorded
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-1873-2025
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 22, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 22, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology